Skip to content

https://newconomy.media/

Primary Menu

https://newconomy.media/

  • News
  • Markets
  • Investing
  • Companies
  • Money
  • Industry news
  • People
  • Home
  • Viola Hernandez

Viola Hernandez

074c24f925c0ecef08ce1bc5e6e45857.jpg
  • Industry news

Red Tape to Turnkey: How Digital Ecosystems Are Flattening Global Real Estate

Viola Hernandez 24 June 2026

If you look at our local market here in the States, the heavy lifting of buying and selling a home...

Read MoreRead more about Red Tape to Turnkey: How Digital Ecosystems Are Flattening Global Real Estate
9ed33da3e56aa276a2c87629ff1d871f.jpg
  • Markets

Biopharma Updates: Sumitomo Surges on US Sales While INmune Bio Pushes Cancer Pipeline

Viola Hernandez 1 April 2026

Sumitomo Pharma is feeling pretty optimistic about its recently ended fiscal year. Riding a wave of strong North American sales,...

Read MoreRead more about Biopharma Updates: Sumitomo Surges on US Sales While INmune Bio Pushes Cancer Pipeline
8b45f660dbb88361253560bb402063c8.jpg
  • Investing

Apple Crushes Earnings Estimates Amidst Historic Gold Volatility

Viola Hernandez 10 February 2026

Markets closed with a mix of optimism and trepidation on Friday as Apple delivered a stunning earnings beat for the...

Read MoreRead more about Apple Crushes Earnings Estimates Amidst Historic Gold Volatility
336334b9f36531ccbca670b6c15f1e62.jpg
  • Markets

Global Pharma and Biotech Update: Palisade Bio Snapshot and Leadership Changes at Linda

Viola Hernandez 19 December 2025

In the fast-moving US biopharmaceutical sector, Carlsbad-based Palisade Bio, Inc. continues to draw attention with its specialized focus on gastrointestinal...

Read MoreRead more about Global Pharma and Biotech Update: Palisade Bio Snapshot and Leadership Changes at Linda

Recent Posts

  • Red Tape to Turnkey: How Digital Ecosystems Are Flattening Global Real Estate
  • Stellantis Flips the Script in Europe: Outsourcing, Brand Demotions, and the Ground-Level EV Disconnect
  • Biopharma Updates: Sumitomo Surges on US Sales While INmune Bio Pushes Cancer Pipeline
  • Tesla’s Next Act: Beyond Automotive Dominance and Into the “Macrohard” Era
  • AvePoint Braces for Earnings: Can ARR Growth Revive Investor Confidence?

Recent Comments

No comments to show.

Archives

  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • December 2025

Categories

  • Companies
  • Industry news
  • Investing
  • Markets
  • News

You may have missed

074c24f925c0ecef08ce1bc5e6e45857.jpg
  • Industry news

Red Tape to Turnkey: How Digital Ecosystems Are Flattening Global Real Estate

Viola Hernandez 24 June 2026
253cc30c351475786101e7d85d61924a.jpg
  • News

Stellantis Flips the Script in Europe: Outsourcing, Brand Demotions, and the Ground-Level EV Disconnect

Roy Wright 22 May 2026
9ed33da3e56aa276a2c87629ff1d871f.jpg
  • Markets

Biopharma Updates: Sumitomo Surges on US Sales While INmune Bio Pushes Cancer Pipeline

Viola Hernandez 1 April 2026
b37037f1a90514c95cc027e9664b1497.jpg
  • Companies

Tesla’s Next Act: Beyond Automotive Dominance and Into the “Macrohard” Era

Roman Rodriguez 19 March 2026
328aa3014bd38117aa1a3a12eee1d629.jpg
  • Investing

AvePoint Braces for Earnings: Can ARR Growth Revive Investor Confidence?

Valerie Scott 27 February 2026
  • Contacts
Copyright © All rights reserved. | CoverNews by AF themes.